Re-lieved 4% Lidocaine Fabric Tape Patch
Product Images NDC 71662-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Re-lieved 4% Lidocaine Fabric Tape (NDC 71662-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Transfer Technology, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug Facts Panel (Canister Drug Facts)

Drug Facts Panel (Canister Drug Facts)
This is a drug information label for a topical medication containing 4% Lidocaine, used for temporary pain relief. It is to be used externally-only on clean and dry skin, and not for a duration of more than 12 hours. There are warnings of possible redness, allergic reactions, and to seek medical attention if conditions persist for more than 7 days. Children under the age of 12 should not use this without consulting a physician first. It is advisable to ask a doctor or pharmacist before use if already using blood thinners, steroids, or non-steroidal anti-inflammatory drugs or if the skin is sensitive. It is important to keep children and pets away from the product and dispose of the used product properly.*
FDA Label Image

Lidocaine 4% Fabric Tape (Tapecanisterblack)

Lidocaine 4% Fabric Tape (Tapecanisterblack)
Re~Lieved is a pain relieving kinesiology tape that contains 4% Lidocaine, offering maximum strength relief for those who suffer from arthritis or other pains. The tape strips are designed to smoothly adhere to the affected area, helping to contour to the specific area of pain. Each package includes 10 strips that are 2 inches by 10 inches in size.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.